GSK GLAXO WELLCOME MANUFACTURING P.

Business Nature: Manufacturing Plant

Company Overview:

GSK Glaxo Wellcome Manufacturing Pte Ltd is a major pharmaceutical manufacturing facility located in Singapore. It operates as a key production site for the global healthcare company GSK (GlaxoSmithKline). The facility specializes in the large-scale manufacturing and processing of high-quality pharmaceutical products and active pharmaceutical ingredients (APIs). As a core part of GSK's global supply chain, the company adheres to strict international quality and safety standards to support the distribution of medicines to global markets. It functions primarily as an industrial production entity rather than a trading company.

Glaxo Wellcome Manufacturing Pte Ltd in Singapore is a key manufacturing site for GSK, primarily focused on the production of active pharmaceutical ingredients (APIs) and respiratory medicines. The products manufactured or associated with this facility include:

Respiratory Medicines:

Ventolin (Salbutamol) - Used for the treatment of asthma and chronic obstructive pulmonary disease.

Seretide (Fluticasone Propionate/Salmeterol) - Used for the management of asthma and COPD.

Flixotide (Fluticasone Propionate) - An inhaled corticosteroid for asthma management.

Active Pharmaceutical Ingredients (APIs):

The facility produces various APIs that serve as the building blocks for GSK global finished pharmaceutical products, particularly those within the respiratory and anti-infective therapeutic areas.

Note: As a manufacturing entity, the site specializes in production and supply chain operations rather than direct sales. Finished pharmaceutical products are distributed globally through GSK's commercial entities.